Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hay

Showing results (201-210 of 654) with videos related to

Pageof 66
Sort By:
The Journal of Pediatrics|May 14, 2018
Neonatal Hyperglycemia-Causes, Treatments, and CautionsWilliam W Hay, Paul J Rozance
Biochemistry|December 20, 1983
Histone deacetylase from HeLa cells: properties of the high molecular weight complexC W Hay, E P Candido
Advances in Experimental Medicine and Biology|January 1, 1987
Application of the Ohmeda Biox 3700 Pulse Oximeter to neonatal oxygen monitoringW W Hay, J Brockway, M Eyzaguirre
Clinical Chemistry|March 1, 1992
Plasma methadone measurements and their role in methadone detoxification programsK Wolff, A W Hay, D Raistrick
Neuro-Oncology|August 13, 2013
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United StatesAndrew Messali, Joel W Hay, Reginald Villacorta
Pharmacoeconomics|August 3, 2014
A review of the economic burden of glioblastoma and the cost effectiveness of pharmacologic treatmentsAndrew Messali, Reginald Villacorta, Joel W Hay
CNS Drugs|October 20, 2014
Cost effectiveness of fingolimod, teriflunomide, dimethyl fumarate and intramuscular interferon-β1a in relapsing-remitting multiple sclerosisXinke Zhang, Joel W Hay, Xiaoli Niu
Cost Effectiveness and Resource Allocation : C/E|November 22, 2018
Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumabYifan Xu, Joel W Hay, Afsaneh Barzi
Methods in Molecular Medicine|March 4, 2006
In vivo techniques for studying fetoplacental nutrient uptake, metabolism, and transportTimothy R H Regnault, William W Hay
International Journal of Cardiology|December 7, 2018
Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal functionJonathan Salcedo, Joel W Hay, Jenny Lam
Pageof 66

Showing results (201-210 of 654) with videos related to

Sort By:
Pageof 66
The Journal of Pediatrics|May 14, 2018
Neonatal Hyperglycemia-Causes, Treatments, and CautionsWilliam W Hay, Paul J Rozance
Biochemistry|December 20, 1983
Histone deacetylase from HeLa cells: properties of the high molecular weight complexC W Hay, E P Candido
Advances in Experimental Medicine and Biology|January 1, 1987
Application of the Ohmeda Biox 3700 Pulse Oximeter to neonatal oxygen monitoringW W Hay, J Brockway, M Eyzaguirre
Clinical Chemistry|March 1, 1992
Plasma methadone measurements and their role in methadone detoxification programsK Wolff, A W Hay, D Raistrick
Neuro-Oncology|August 13, 2013
The cost-effectiveness of temozolomide in the adjuvant treatment of newly diagnosed glioblastoma in the United StatesAndrew Messali, Joel W Hay, Reginald Villacorta
Pharmacoeconomics|August 3, 2014
A review of the economic burden of glioblastoma and the cost effectiveness of pharmacologic treatmentsAndrew Messali, Reginald Villacorta, Joel W Hay
CNS Drugs|October 20, 2014
Cost effectiveness of fingolimod, teriflunomide, dimethyl fumarate and intramuscular interferon-β1a in relapsing-remitting multiple sclerosisXinke Zhang, Joel W Hay, Xiaoli Niu
Cost Effectiveness and Resource Allocation : C/E|November 22, 2018
Impact of drug substitution on cost of care: an example of economic analysis of cetuximab versus panitumumabYifan Xu, Joel W Hay, Afsaneh Barzi
Methods in Molecular Medicine|March 4, 2006
In vivo techniques for studying fetoplacental nutrient uptake, metabolism, and transportTimothy R H Regnault, William W Hay
International Journal of Cardiology|December 7, 2018
Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal functionJonathan Salcedo, Joel W Hay, Jenny Lam
Pageof 66